These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 1412197)
21. PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects. Seguí R; Estellés A; Mira Y; España F; Villa P; Falcó C; Vayá A; Grancha S; Ferrando F; Aznar J Br J Haematol; 2000 Oct; 111(1):122-8. PubMed ID: 11091191 [TBL] [Abstract][Full Text] [Related]
22. Tissue-type plasminogen activator, plasminogen activator inhibitor, and histidine-rich glycoproteins in stressed human newborns. Corrigan JJ; Jeter MA Pediatrics; 1992 Jan; 89(1):43-6. PubMed ID: 1728019 [TBL] [Abstract][Full Text] [Related]
23. Homozygous protein C deficiency combined with heterozygous dysplasminogenemia found in a 21-year-old thrombophilic male. Manabe S; Matsuda M Thromb Res; 1985 Aug; 39(3):333-41. PubMed ID: 3840289 [TBL] [Abstract][Full Text] [Related]
24. Prospective double-arm study of fibrinolysis in surgical patients. Kosir MA; Schmittinger L; Barno-Winarski L; Duddella P; Pone M; Perales A; Lange P; Brish LK; McGee K; Beleski K; Pawlak J; Mammen E; Sajahan NP; Kozol RA J Surg Res; 1998 Jan; 74(1):96-101. PubMed ID: 9536981 [TBL] [Abstract][Full Text] [Related]
25. Effects of simvastatin on cigarette smoke extract induced tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in human umbilical vein endothelial cells. Hu XY; Ma YH; Wang C; Yang YH Chin Med J (Engl); 2009 Oct; 122(19):2380-5. PubMed ID: 20079143 [TBL] [Abstract][Full Text] [Related]
26. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Nilsson IM; Ljungnér H; Tengborn L Br Med J (Clin Res Ed); 1985 May; 290(6480):1453-6. PubMed ID: 3922531 [TBL] [Abstract][Full Text] [Related]
27. Familial clustering of defective release of t-PA. Petäjä J; Rasi V; Vahtera E; Myllylä G Br J Haematol; 1991 Oct; 79(2):291-5. PubMed ID: 1958488 [TBL] [Abstract][Full Text] [Related]
28. Altered fibrinolysis in DVT: influence of site of sampling. Han P; Koay ES; Tsakok M; Aw TC; Wong LY; Pradhan M Thromb Haemost; 1988 Aug; 60(1):50-3. PubMed ID: 3142091 [TBL] [Abstract][Full Text] [Related]
29. Constitutional heparin co-factor II deficiency associated with recurrent thrombosis. Sie P; Dupouy D; Pichon J; Boneu B Lancet; 1985 Aug; 2(8452):414-6. PubMed ID: 2863445 [TBL] [Abstract][Full Text] [Related]
30. Inherited deficiency of protein S in a Japanese family with recurrent venous thrombosis: a study of three generations. Kamiya T; Sugihara T; Ogata K; Saito H; Suzuki K; Nishioka J; Hashimoto S; Yamagata K Blood; 1986 Feb; 67(2):406-10. PubMed ID: 2935209 [TBL] [Abstract][Full Text] [Related]
31. A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency. Zöller B; García de Frutos P; Dahlbäck B Thromb Haemost; 1998 Apr; 79(4):802-7. PubMed ID: 9569196 [TBL] [Abstract][Full Text] [Related]
32. Deficient tissue plasminogen activator release and normal tissue plasminogen activator inhibitor in a patient with recurrent deep vein thrombosis. Latham B; Kafoy EA; Barrett O; Gonzalez MF Am J Med; 1990 Feb; 88(2):199-200. PubMed ID: 2105644 [No Abstract] [Full Text] [Related]
33. Impaired fibrinolytic activity induced by ingestion of butter: effect of increased plasma lipids on the fibrinolytic activity. Kozima Y; Urano T; Serizawa K; Takada Y; Takada A Thromb Res; 1993 Apr; 70(2):191-202. PubMed ID: 8322287 [TBL] [Abstract][Full Text] [Related]
34. [Post-mortem concentration of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI-1) in the vitreous body of the human eye]. Przygońska J; Kotschy M; Sliwka K; Kulwas A Klin Oczna; 1996 Mar; 98(3):205-8. PubMed ID: 9019590 [TBL] [Abstract][Full Text] [Related]
35. Plasminogen activators and their inhibitors in non-small cell lung cancer. Low content of type 2 plasminogen activator inhibitor associated with tumor dissemination. Nagayama M; Sato A; Hayakawa H; Urano T; Takada Y; Takada A Cancer; 1994 Mar; 73(5):1398-405. PubMed ID: 8111706 [TBL] [Abstract][Full Text] [Related]
36. [Hypofibrinolysis after venous occlusion in patients treated with long-term hemodialysis]. Opatrný K; Vít L; Opatrná S; Sulková S; Bodláková B Cas Lek Cesk; 1994 May; 133(11):346-9. PubMed ID: 8004664 [TBL] [Abstract][Full Text] [Related]
37. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies. Colucci M; Altomare DF; Chetta G; Triggiani R; Cavallo LG; Semeraro N Thromb Haemost; 1988 Aug; 60(1):25-9. PubMed ID: 3142090 [TBL] [Abstract][Full Text] [Related]
39. Amounts of tPA and PAI-1 in the euglobulin fraction obtained at different pH: their relation to the euglobulin clot lysis time. Urano T; Nishikawa T; Nagai N; Takada Y; Takada A Thromb Res; 1997 Oct; 88(1):75-80. PubMed ID: 9336876 [No Abstract] [Full Text] [Related]
40. The acute effect of a single very high dose of N-3 fatty acids on coagulation and fibrinolysis. Møller JM; Svaneborg N; Lervang HH; Varming K; Madsen P; Dyerberg J; Schmidt EB Thromb Res; 1992 Sep; 67(5):569-77. PubMed ID: 1448789 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]